SCHEMBL23340960

SCHEMBL23340960

Cc1cc(C)c(C(=O)c2[nH]c(-c3ccc(C(C)(C)C)cc3)cc2-c2ccc(C(C)(C)C)cc2)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.40
RXRB P28702 2/20 0.38
RXRA P19793 1/20 0.38
HSD17B2 P37059 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GRIN2C Q14957 1/20 0.35
KMT2A Q03164 2/20 0.34
MITF O75030 1/20 0.34
TP53 P04637 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
PTGER2 P43116 1/20 0.34
TNKS O95271 2/20 0.33
PARP1 P09874 2/20 0.33
TNKS2 Q9H2K2 2/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23758527 0.86 GCGR (0.47) GCGRALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL2787332 0.79 SRD5A2 (0.43) GCGRALDH1A1SMN1; SMN2KMT2AAKR1C3
SCHEMBL23758526 0.78 GSK3B (0.47) GCGRALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL1312388 0.75 MAPT (0.50) ALDH1A1LMNASMN1; SMN2KDM4EGRIN2C
SCHEMBL13183793 0.75 GCGR (0.42) GCGRALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL23758519 0.73 SGK1 (0.39) GCGRRXRBRXRASMN1; SMN2KDM4E
SCHEMBL1311467 0.73 MAPT (0.49) GCGRKMT2APTGER2TNKSTNKS2
SCHEMBL13183667 0.71 GCGR (0.42) GCGRALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL24791093 0.71 GSK3B (0.33) GCGRGRIN2CPTGER2
SCHEMBL2790467 0.70 MAPT (0.51) ALDH1A1LMNASMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220407007-A1 LIGHT-EMITTING ELEMENT MATERIAL CONTAINING PYRROMETHENE BORON COMPLEX, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE TORAY INDUSTRIES, INC. (JP) 2022-12-22 US disclosed
WO-2021085460-A1 LIGHT-EMITTING ELEMENT MATERIAL CONTAINING PYRROMETHENE BORON COMPLEX, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE 東レ株式会社 2021-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407007-A1 LIGHT-EMITTING ELEMENT MATERIAL CONTAINING PYRROMETHENE BORON COMPLEX, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE NR2E3, CRY1, GRK1 GCGR 504/4885RXRB 108/4885RXRA 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.